These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15858144)

  • 1. Molecular classification of renal tumors by gene expression profiling.
    Schuetz AN; Yin-Goen Q; Amin MB; Moreno CS; Cohen C; Hornsby CD; Yang WL; Petros JA; Issa MM; Pattaras JG; Ogan K; Marshall FF; Young AN
    J Mol Diagn; 2005 May; 7(2):206-18. PubMed ID: 15858144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
    Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
    Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
    Young AN; Amin MB; Moreno CS; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS
    Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical diagnosis of renal neoplasms.
    Truong LD; Shen SS
    Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays.
    Young AN; de Oliveira Salles PG; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS; Amin MB
    Am J Surg Pathol; 2003 Feb; 27(2):199-205. PubMed ID: 12548166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.
    Shen SS; Krishna B; Chirala R; Amato RJ; Truong LD
    Mod Pathol; 2005 Jul; 18(7):933-40. PubMed ID: 15696118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of renal neoplasms based on molecular signatures.
    Yang XJ; Sugimura J; Schafernak KT; Tretiakova MS; Han M; Vogelzang NJ; Furge K; Teh BT
    J Urol; 2006 Jun; 175(6):2302-6. PubMed ID: 16697863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances of immunohistochemistry for diagnosis of renal tumors.
    Kuroda N; Tanaka A; Ohe C; Nagashima Y
    Pathol Int; 2013 Aug; 63(8):381-90. PubMed ID: 23957913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
    Slater AA; Alokail M; Gentle D; Yao M; Kovacs G; Maher ER; Latif F
    Epigenetics; 2013 Mar; 8(3):252-67. PubMed ID: 23428843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
    Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell tumors with an entrapped papillary component: a collision with predilection for oncocytic tumors.
    Williamson SR; Cheng L; Gadde R; Giannico GA; Wasco MJ; Taylor Smith PJ; Gupta NS; Grignon DJ; Jorda M; Kryvenko ON
    Virchows Arch; 2020 Mar; 476(3):399-407. PubMed ID: 31444626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.